News
ICON Reports Second Quarter 2022 Results
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the second quarter ended June 30, 2022.
CEO Dr. Steve
Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
Novocure today announced the recipients of the 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program. The AACR-Novocure Grants for Tumor Treating Fields Research Program
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
QIAGEN ergänzt digitales PCR-Portfolio QIAcuity um neue Biopharma-Produkte und führt Expert Custom Assay Design Service ein
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute mehrere Erweiterungen seiner Instrumente für digitalen PCR (dPCR) der QIAcuity-Serie bekannt. Mit den Neuerungen soll der Einsatz des
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a series of enhancements for its QIAcuity series of digital PCR (dPCR) instruments designed to drive greater use among customers
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a series of enhancements for its QIAcuity series of digital PCR (dPCR) instruments designed to drive greater use among customers
QIAGEN übertrifft Ausblick für zweites Quartal und erhöht Prognose für das Gesamtjahr 2022
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Ergebnisse für das zweite Quartal 2022 bekannt und hob die Prognose für das Gesamtjahr 2022 an.
Der Konzernumsatz sank im
QIAGEN beats outlook for Q2 2022 and raises full-year 2022 outlook
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results for the second quarter of 2022 and increased the outlook for full-year 2022.
Net sales for Q2 2022 declined 9% (-4% at
Cosmo and Sun Pharma Announce Territory Expansion of License and Supply Agreements for WINLEVI® to include Japan, Australia, New Zealand, Brazil, Mexico and Russia
DGAP-Adhoc: BB Biotech AG publishes its interim report
DGAP-News: BB BIOTECH AG: First signs of increased M&A activity due to attractive valuations
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its decision-support software platform QIAGEN Clinical Insights (QCI) has been used to interpret more than three million
QIAGENs Plattform zur Unterstützung von klinischen Entscheidungsfindungen überschreitet Marke von drei Millionen NGS-Patiententests
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass mit QIAGEN Clinical Insights (QCI), der unternehmenseigenen Plattform zur Unterstützung klinischer Entscheidungsfindungen
Acadia Healthcare Forms Joint Venture With ECU Health to Build a Modern Behavioral Health Hospital in Eastern North Carolina
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with ECU Health (formerly Vidant Health), eastern North Carolina’s premier health system. The new
ECU Health Partners With Acadia Healthcare to Build a New Behavioral Health Hospital Expanding Access to Behavioral Health Services
ECU Health and Acadia Healthcare announced today plans to build a state-of-the-art, 144-bed behavioral health hospital in the medical district of Greenville, N.C., less than a mile from ECU Health
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
AMN Healthcare Report: Orthopedic Surgeons Offered the Highest Physician Starting Salary at $565,000
Orthopedic surgeons are offered the highest average starting salary among physicians and advanced practice professionals, according to an annual report from AMN Healthcare and its physician search
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Acadia Healthcare Announces Date for Second Quarter 2022 Earnings Release
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2022 results on Wednesday, July 27, 2022, after the close of the market. Acadia will conduct a
Extension of the postponement of the settlement of Vifor Pharma tender offer
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220712006199/en/
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
CSL
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Premier, Inc. to Report Fiscal 2022 Fourth-Quarter and Full-Year Results and Host Conference Call on August 16, 2022
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2022 fourth quarter and full year on Tuesday, August 16, 2022, at approximately 6:30 a.m. ET. The
Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2022 financial results on Wednesday, August 3rd, before the market opens. A conference call has been scheduled